The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
HL, not the cheapest but the best.
Yes you would.
How is anyone getting quotes under 90p?
Well 212 have just stopped people buying in one clean sweep. So that is a lot of people who can sell but no longer buy, all i'm saying is if you have what other people want don't give it to them.
I hold shares and people want them.
Look how many people cannot buy before you decide to sell.
The only people selling will be those who think they can buy cheaper later today or tomorrow. I was doing it last week but we're too close to the bell now to be playing games.
Sell now and risk losing your divi.
100p is more a mental barrier than a physical one I think, lots of people see it and sell, it will break then 120+ will come much quicker.
Do you think the earth is flat?
1.29 over in the states, this will gap up again tomorrow. Just some people didn't want to be sweating in bed tonight.
Evraz are selling £5 notes for 50p each. How many do you want?
I've seen so many people comment here and twitter and forums battering anyone investing here, labelled as 'stupid' and 'uneducated'.
Grow up, the market is simple sometimes and because more than one person here can see the opportunity doesn't mean it doesn't exist.
There is in my opinion no way you can lose money here even in the worse case scenario.
My personal journey reads;
22k shares @ 75p = £16500
Dividends paid 30th March - £7800
Reinvest @ between 100-150p (say 125p) - Extra 10k shares.
At that stage (@ 1.25) be at £40k. £40k potential in 25 days time.
Okay but long term this goes back to 300p and provides say 60/80p per share per year dividends. What an opp.
I don't see any reason why they wouldn't issue Divi's. Would be a great 'recovery' move for the company as it would be seen as investors as a great dividend income (resulting in a probable rise in SP) and also would predict somewhere between 40-50% of the dividend payment would be re-invested into the company at this suppressed price.
I can see both points regarding the RNS, it can be read in both ways of it being added back into EVR stock price and yet to be priced in or demerger happened/happening but at nil value.
Regardless of meaning fundamentally this share is undervalued massively on so many factors that have been discussed. Let's just say after reading the rns I'm having a better night sleep being long than I would be if I was short. Either way both parties are having a better night sleep than the horror being endured by Ukranian families.
Hopefully these ceasefire talks come to fruition for their sake.
Div yield showing 203%. Even the most risk adverse must see the opportunity here
POLY & EVR will both do very well from here, maybe just on alternate days for the time being because of the volatility. EVR is the one to trade today but LTH will do well out of both.
Anything under 100p sets you and your family up for life. Buy, hold and delete your trading apps. This opportunity comes once a lifetime. I've sold all my assets to buy.
$0.50 per share so 37p ish. Just FYI, still ludicrously cheap
or 'jump' off
The market is missing the blaringly obvious here.
Dr Vladislav Sandler, Co-Founder and Chief Executive Officer, Hemogenyx Pharmaceuticals, commented: "I am very excited to be on the West Side of Manhattan in the historic Manhattanville Factory District. Having toured every life sciences option in the New York City area, the choice for our lab's continued growth was clear. With several current and future vivarium options, the opportunity to collaborate with nearby Columbia University and City College, the convenient location for our staff, and Janus's commitment to the life sciences industry and our company, the Mink Building represents an unmatched combination of advantages. We will be growing our staff and operations significantly over the next three years, and this lab and building provide us everything we need. Janus also provides us with the critical flexibility we need for our future, by allowing us to grow out of this lab and into its numerous other properties in the District without penalty."
Pre-market 42.45 +2.86 (7.22%)
Up 7.22% on a 5.75bn Market Cap.
Values the news at 410 million. Would equate to a 2500% rise for us. Just being silly, but shows how ridiculous the money to be made here could potentially be.